REVLIMID
REVLIMID
Approved
DIN Number
02317699
Drug Class
Human
Market Date
Oct 10, 2008
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02317699
AIG Number0152422003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX04 LENALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LENALIDOMIDEActive
Strength: 15 MG
Monograph: LENALIDOMIDE